Suven Pharmaceuticals’ wholly owned subsidiary company -- Suven Pharma, Inc., (SPI) has divested its stake in Rising Pharma Holdings, Inc., USA to Raisin Aggregator, L.P. USA one of the investment arm of H.I.G. Capital (H.I.G), a leading global alternative investment firm with over $45 billion of equity capital under management. H.I.G. has made a strategic equity investment into Rising Pharma Holdings and Casper Pharma (collectively ‘Rising Pharmaceuticals’), a leading provider of generic and specialty pharmaceuticals in the United States. As part of the structured deal Suven Pharma Inc., USA received cash and 7% stake in Raisin Aggregator, L.P. USA, the new company.
Suven Pharma, Inc, will become an investor in the new company as part of deal. H.I.G. is partnering with current management of Rising Pharmaceuticals, to continue the Company’s strong track record for growth and to support new initiatives such as M&A and new product launches etc.
Suven Pharmaceuticals is a bio-pharmaceutical company, incorporated with the object of being engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.50 |
Dr. Reddys Lab | 1342.45 |
Cipla | 1472.45 |
Lupin | 2147.55 |
Zydus Lifesciences | 973.90 |
View more.. |